Debate Continues Over H.R. 1 Medicaid Changes as Millions Risk Losing Coverage
Will Implementation Create Sweeping Losses or a Return to Balance and Self-Sufficiency?
In Their Own Words
The following excerpt is from an op-ed that first appeared in MedPage Today on February 24th, 2024.
If you head to the Florida beaches for spring break, you will notice that the Canadian Maple Leaf is often present among the flags outside hotels and tourist apartments. The benefit to Florida from the annual migration of snowbirds from the North has long been evident, but now something more unusual may be coming from Canada.
On January 5, the FDA approved (with conditions) a request from Gov. Ron DeSantis (R.-Fla.) to import prescription drugs from Canada, making Florida the first state ever given authority to import prescription drugs from another country. The Florida Medicaid program is likely hard at work now devising a plan to source large quantities of drugs from Canada, where unit prices are often small fractions of the U.S. list price.
This unprecedented plan begs many questions: Why is it happening in the first place? Who will benefit from or be harmed by this practice? Could it spread to other U.S. states?
Read the entire op-ed here.

Will Implementation Create Sweeping Losses or a Return to Balance and Self-Sufficiency?
An LDI Fellow and Chronic Pain Researcher Call on Health Plans To Lower Barriers to Physical Therapy, Acupuncture, and Interdisciplinary Pain Care
Chart of the Day: Researchers Urge Easier Renewals and Better Support To Prevent Gaps in Care
While They Wait for Medicare, People Approved for Social Security Disability Die at Higher Rates Compared to the General Public
Two Pediatricians Share Key Dates and Practical Next Steps
Medicare’s Payment Plan Can Ease Seniors’ Crushing Drug Costs but Medicare Buries it in the Fine Print